It may be weighing on the broader market but in terms of stock specific factors to this point it has little to no influence on SEH.
This is about s/holder churn and long term profit taking - which has been a bit of a surprise given the fundamental momentum in this business but a function of multiple capital raisings over the journey.
In addition it is still a day trader's stock which accentuates the move in both directions.
Share your sentiments on a peaceful resolution.
- Forums
- ASX - By Stock
- SEH
- north korea
north korea, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SEH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online